These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 8926059

  • 21. Interleukin 1: an important mediator of host resistance against Pneumocystis carinii.
    Chen W, Havell EA, Moldawer LL, McIntyre KW, Chizzonite RA, Harmsen AG.
    J Exp Med; 1992 Sep 01; 176(3):713-8. PubMed ID: 1387414
    [Abstract] [Full Text] [Related]

  • 22. Specific T-cell response to a Pneumocystis carinii surface glycoprotein (gp120) after immunization and natural infection.
    Fisher DJ, Gigliotti F, Zauderer M, Harmsen AG.
    Infect Immun; 1991 Oct 01; 59(10):3372-6. PubMed ID: 1894351
    [Abstract] [Full Text] [Related]

  • 23. Interleukin-6 production in a murine model of Pneumocystis carinii pneumonia: relation to resistance and inflammatory response.
    Chen W, Havell EA, Gigliotti F, Harmsen AG.
    Infect Immun; 1993 Jan 01; 61(1):97-102. PubMed ID: 8418070
    [Abstract] [Full Text] [Related]

  • 24. Antibodies to Pneumocystis carinii in Danish blood donors and AIDS patients with and without Pneumocystis carinii pneumonia.
    Buhl L, Settnes OP, Andersen PL.
    APMIS; 1993 Sep 01; 101(9):707-10. PubMed ID: 8240790
    [Abstract] [Full Text] [Related]

  • 25. Pneumocystis carinii enhances soluble mannose receptor production by macrophages.
    Fraser IP, Takahashi K, Koziel H, Fardin B, Harmsen A, Ezekowitz RA.
    Microbes Infect; 2000 Sep 01; 2(11):1305-10. PubMed ID: 11018446
    [Abstract] [Full Text] [Related]

  • 26. Latency is not an inevitable outcome of infection with Pneumocystis carinii.
    Chen W, Gigliotti F, Harmsen AG.
    Infect Immun; 1993 Dec 01; 61(12):5406-9. PubMed ID: 7901169
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Intranasal immunization confers protection against murine Pneumocystis carinii lung infection.
    Pascale JM, Shaw MM, Durant PJ, Amador AA, Bartlett MS, Smith JW, Gregory RL, McLaughlin GL.
    Infect Immun; 1999 Feb 01; 67(2):805-9. PubMed ID: 9916094
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pneumocystis carinii host origin defines the antibody specificity and protective response induced by immunization.
    Gigliotti F, Harmsen AG.
    J Infect Dis; 1997 Nov 01; 176(5):1322-6. PubMed ID: 9359734
    [Abstract] [Full Text] [Related]

  • 35. Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model.
    Shellito JE, Kolls JK, Olariu R, Beck JM.
    J Infect Dis; 1996 Feb 01; 173(2):432-9. PubMed ID: 8568306
    [Abstract] [Full Text] [Related]

  • 36. Lymphocytes in host defense against Pneumocystis carinii.
    Beck JM, Harmsen AG.
    Semin Respir Infect; 1998 Dec 01; 13(4):330-8. PubMed ID: 9872630
    [Abstract] [Full Text] [Related]

  • 37. Serum antibody responses to Pneumocystis carinii among different strains of normal and athymic mice.
    Walzer PD, Rutledge ME.
    Infect Immun; 1982 Feb 01; 35(2):620-6. PubMed ID: 6976938
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Combination exposure to zidovudine plus sulfamethoxazole-trimethoprim diminishes B-lymphocyte immune responses to Pneumocystis murina infection in healthy mice.
    Feola DJ, Garvy BA.
    Clin Vaccine Immunol; 2006 Feb 01; 13(2):193-201. PubMed ID: 16467325
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.